Horseradish Peroxidase Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Grade I, Grade II, Grade III, Others), By Application (Immunoassays, Biosensors, Others), By End-use (Hospitals and Clinics, Pharmaceuticals and Biotech, Academic and Research, Others), By Region, and By Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 70.05 Million
CAGR (2026-2031)	7.92%
Fastest Growing Segment	Grade III
Largest Market	North America
Market Size (2031)	USD 110.67 Million

Market Overview

The Global Horseradish Peroxidase Market will grow from USD 70.05 Million in 2025 to USD 110.67 Million by 2031 at a 7.92% CAGR. Horseradish Peroxidase (HRP) is a hemoprotein enzyme extracted from the roots of the horseradish plant, widely utilized in biochemistry applications such as ELISA, Western blotting, and immunohistochemistry for its ability to amplify weak signals by oxidizing substrates in the presence of hydrogen peroxide. The market is fundamentally driven by the escalating global prevalence of chronic and infectious diseases, which creates sustained demand for high-sensitivity diagnostic assays, alongside robust growth in pharmaceutical research requiring reliable detection reagents. These drivers are distinct from broader trends, such as laboratory automation, as they represent the core necessity for biological analysis tools.

One significant challenge impeding market expansion is the vulnerability of the raw material supply chain, as production depends on the agricultural yield and quality of horseradish roots, which are susceptible to environmental factors. According to MedTech Europe, in 2024, the European medical technology market was estimated to be roughly €170 billion, a figure that underscores the substantial economic scale of the diagnostic and laboratory sectors that heavily rely on critical enzymatic reagents like horseradish peroxidase.

Key Market Drivers

The rising prevalence of chronic and infectious diseases acts as a primary catalyst for the horseradish peroxidase market, necessitating robust diagnostic tools for early detection and disease monitoring. This enzyme is a critical component in enzyme-linked immunosorbent assays and immunohistochemistry, where it conjugates with antibodies to visualize target antigens associated with complex pathologies. The demand for these assays is directly correlated with the growing burden of malignancy, which requires precise histological analysis for effective treatment planning. According to the American Cancer Society, January 2024, in the 'Cancer Facts & Figures 2024', the number of new cancer cases in the United States was projected to exceed 2 million for the first time, signaling an intensified need for reliable biomarker detection reagents in clinical pathology.

Simultaneously, a surge in pharmaceutical and biotechnology research and development expenditure is expanding the utilization of this enzyme in drug discovery and high-throughput screening. Laboratories extensively employ peroxidase-based detection systems to validate protein interactions and therapeutic efficacy during the development of novel biologics. This trend is supported by substantial financial commitments from major industry players aiming to accelerate clinical pipelines and regulatory approvals. According to the Pharmaceutical Research and Manufacturers of America, August 2024, in the '2024 PhRMA Annual Membership Survey', member companies reported a record investment of $103 billion in research and development during 2023. Furthermore, the broader infectious disease landscape continues to influence reagent consumption. According to the World Health Organization, in 2024, approximately 8.2 million people were newly diagnosed with tuberculosis globally in the preceding year, underscoring the persistent requirement for enzymatic reagents in global health surveillance.

Download Free Sample Report

Key Market Challenges

The vulnerability of the raw material supply chain presents a formidable obstacle to the expansion of the Global Horseradish Peroxidase Market. Since the enzyme is extracted directly from the roots of the horseradish plant, the industry is intrinsically tied to agricultural cycles and environmental stability. Adverse weather conditions, such as prolonged droughts or heavy flooding, can drastically diminish crop yields and compromise the quality of the roots, leading to shortages of the high-activity biomass needed for extraction. This biological constraint creates a volatile supply foundation for diagnostic manufacturers who require consistent reagent availability, directly hampering market predictability and growth.

This instability is significantly amplified by the high geographic concentration of the crop's cultivation. According to the Illinois Farm Bureau, in 2024, the state of Illinois produced more than two-thirds of the entire horseradish supply for the United States. This intense centralization means that a single regional climate event can disrupt the primary global source of the raw material. Consequently, this bottleneck constricts the availability of the essential base required for the enzyme, forcing the market to contend with fluctuating supply levels and preventing steady industrial expansion.

Key Market Trends

The transition towards recombinant production methods is fundamentally reshaping the Global Horseradish Peroxidase Market by addressing the critical vulnerabilities of agricultural extraction. Manufacturers are increasingly moving away from dependence on horseradish roots to synthetic biology techniques, ensuring a consistent, scalable supply of high-purity enzymes essential for precise immunoassay formulation. This strategic pivot allows suppliers to mitigate environmental risks while meeting the stringent quality standards required for next-generation diagnostics. According to Merck KGaA, April 2024, in the 'Merck Invests More Than € 300 Million in New Life Science Research Center in Germany' press release, the company announced a strategic investment of over €300 million to construct a facility dedicated to researching solutions for manufacturing antibodies and recombinant proteins, aiming to secure future biotechnological production capacities.

Simultaneously, the integration of horseradish peroxidase into microfluidic Point-of-Care (POC) diagnostic platforms represents a major technological leap toward decentralized testing. These micro-scale systems leverage the enzyme's rapid kinetics to deliver laboratory-grade sensitivity within portable devices, facilitating immediate clinical decision-making outside traditional hospital environments. The development of such platforms is being aggressively supported by targeted funding to accelerate commercial availability. According to FinSMEs, November 2024, in the 'Novel Microdevices Receives Approx. $2.7M Follow on Funding from NIH RADx Tech' article, the company secured $2.68 million to advance its high-performance diagnostic device, underscoring the robust capital flow fueling the expansion of microfluidic technologies in the diagnostic sector.

Segmental Insights

The Grade III segment is currently identified as the fastest-growing category within the Global Horseradish Peroxidase Market, driven by its expanding utility in industrial and environmental applications. Unlike higher-purity grades restricted to sensitive clinical diagnostics, Grade III is increasingly favored for large-scale processes, such as bioremediation and wastewater treatment, due to its cost-effectiveness and sufficient catalytic activity. Additionally, the rising volume of basic research and the manufacturing of economical diagnostic reagents in developing regions further bolster demand. This trend reflects a market preference for versatile, budget-friendly enzymatic solutions suitable for bulk commercial usage.

Regional Insights

North America maintains a dominant position in the Global Horseradish Peroxidase Market, driven by its expansive pharmaceutical and biotechnology industries. The region experiences high demand for this enzyme due to its critical role in research applications, particularly within immunoassays and clinical diagnostics. Furthermore, established regulatory frameworks, such as those overseen by the U.S. Food and Drug Administration, provide clear guidelines for the approval of diagnostic products that utilize peroxidase conjugates. This supportive infrastructure, combined with substantial investment in life sciences, ensures steady utilization of horseradish peroxidase across academic and commercial laboratories in the region.

Recent Developments

• In September 2024, Bio-Techne Corporation showcased its VisUCyte™ HRP Polymer Detection Kits at the 7th European Congress of Immunology (ECI 2024) in Dublin. The company highlighted the kits' ability to deliver rapid and specific tissue staining for immunohistochemistry applications without the need for biotin-based detection systems. By utilizing a polymer backbone conjugated with numerous horseradish peroxidase enzymes, the technology offered increased assay sensitivity and reduced primary antibody consumption. This presentation underscored Bio-Techne's commitment to providing advanced reagents that streamline workflows and improve reproducibility for immunology and pathology researchers.
• In July 2024, Agrisera AB, a Swedish company specializing in antibody production, became part of Thermo Fisher Scientific following the latter's acquisition of Olink Proteomics. Agrisera, known for its extensive catalog of antibodies including those conjugated with horseradish peroxidase (HRP), integrated its operations into the global life sciences organization. This development provided Thermo Fisher Scientific with an expanded portfolio of high-quality antibodies and reagents to support plant science and general bioresearch. The transition aimed to leverage Thermo Fisher’s global reach to increase the accessibility of Agrisera’s products, including its HRP-based detection tools, to the scientific community.
• In April 2024, BBI Solutions OEM Limited officially finalized the acquisition of IBEX Technologies Inc., a Montréal-based developer and manufacturer of high-precision recombinant enzymes. BBI Solutions acquired all issued and outstanding shares of IBEX for a total consideration of approximately C$37.9 million. This acquisition was designed to enhance BBI’s portfolio of recombinant proteins and immunodiagnostic reagents, specifically strengthening its position in the global market for critical raw materials used in in vitro diagnostics. The integration of IBEX’s enzyme technologies was expected to support the growing demand for standardized and reliable diagnostic testing components.
• In January 2024, Vector Laboratories and Navinci Diagnostics announced a strategic collaboration to develop novel spatial proteomic tools for biomarker discovery. This partnership aimed to combine Vector Laboratories' expertise in protein and glycan detection systems with Navinci's in situ proximity ligation assay technology. The collaboration focused on creating advanced tools that allow researchers to detect specific protein glycosylation in tissue samples, addressing a significant challenge in the field. The companies planned to launch these innovative solutions to support biopharmaceutical discovery and provide deeper insights into post-translational modifications in a spatial context.

Key Market Players

• Abcam Limited
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories Inc.
• Merck KGaA
• Baduhenna Topco Limited
• Takara Bio Inc.
• Promega Corporation
• GenScript Biotech Corporation
• F. Hoffmann-La Roche Ltd
• TOYOBO Co., Ltd.

By Product Type	By Application	By End-use	By Region
Grade I Grade II Grade III Others	Immunoassays Biosensors Others	Hospitals and Clinics Pharmaceuticals and Biotech Academic and Research Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Horseradish Peroxidase Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Horseradish Peroxidase Market, By Product Type:

• Grade I
• Grade II
• Grade III
• Others

• Horseradish Peroxidase Market, By Application:

• Immunoassays
• Biosensors
• Others

• Horseradish Peroxidase Market, By End-use:

• Hospitals and Clinics
• Pharmaceuticals and Biotech
• Academic and Research
• Others

• Horseradish Peroxidase Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE